We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$7.23B
AUM Growth
+$298M
(+4.3%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
2.07%
Top 10 Holdings %
Top 10 Hldgs %
15.39%
Holding
1,100
New
151
Increased
415
Reduced
333
Closed
164
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$40.6M |
| 2 |
Autodesk
ADSK
|
+$38.8M |
| 3 |
Intuit
INTU
|
+$37.1M |
| 4 |
Ecolab
ECL
|
+$35.6M |
| 5 |
Coca-Cola
KO
|
+$35.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$51.9M |
| 2 |
EOG Resources
EOG
|
+$33.8M |
| 3 |
DATA
Tableau Software, Inc.
DATA
|
+$32M |
| 4 |
Microsoft
MSFT
|
+$29.8M |
| 5 |
Ford
F
|
+$29.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.67% |
| 2 | Financials | 17.68% |
| 3 | Consumer Discretionary | 13.74% |
| 4 | Industrials | 11.53% |
| 5 | Healthcare | 11.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRY
651
DELISTED
Berry Corp
BRY
| $944K | 0.01% |
+89,045
| New | +$1.01M |
|
652
V2X
VVX
$2.62B
| $939K | 0.01% |
23,157
-48,334
| -68% | -$1.77M |
|
653
TG Therapeutics
TGTX
$8.58B
| $934K | 0.01% |
+108,000
| New | +$816K |
|
|
LBAI
654
DELISTED
Lakeland Bancorp Inc
LBAI
| $929K | 0.01% |
57,532
-4,279
| -7% | -$68K |
|
655
Gartner
IT
$9.41B
| $921K | 0.01% |
+5,720
| New | +$894K |
|
|
ALEX
656
DELISTED
Alexander & Baldwin
ALEX
| $915K | 0.01% |
39,631
+8,190
| +26% | +$194K |
|
|
CMRX
657
DELISTED
Chimerix, Inc.
CMRX
| $906K | 0.01% |
209,695
+132,708
| +172% | +$408K |
|
|
EGRX
658
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $905K | 0.01% |
+16,246
| New | +$847K |
|
659
Curtiss-Wright
CW
$27.7B
| $901K | 0.01% |
7,088
-8,380
| -54% | -$965K |
|
660
First Financial Corp
THFF
$922M
| $901K | 0.01% |
22,427
+380
| +2% | +$15.3K |
|
661
WesBanco
WSBC
$3.95B
| $894K | 0.01% |
23,187
-18,057
| -44% | -$695K |
|
662
Arrowhead Research
ARWR
$12.1B
| $888K | 0.01% |
33,500
| – | – |
|
|
AHT
663
Ashford Hospitality Trust
AHT
$21M
| $883K | 0.01% |
301
-79
| -21% | -$370K |
|
|
FTSI
664
DELISTED
FTS International, Inc. Common Stock
FTSI
| $883K | 0.01% |
7,909
+6,949
| +724% | +$1.15M |
|
665
Hawaiian Electric Industries
HE
$2.33B
| $876K | 0.01% |
20,120
| – | – |
|
|
EB
666
DELISTED
Eventbrite
EB
| $872K | 0.01% |
+53,830
| New | +$1,000K |
|
|
LTS
667
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
| $872K | 0.01% |
254,105
+25,686
| +11% | +$88.8K |
|
668
Expedia Group
EXPE
$31.2B
| $871K | 0.01% |
+6,550
| New | +$807K |
|
669
1st Source
SRCE
$2.07B
| $862K | 0.01% |
18,572
+5,000
| +37% | +$229K |
|
670
NETGEAR
NTGR
$669M
| $849K | 0.01% |
33,582
-61,036
| -65% | -$1.78M |
|
671
Financial Institutions
FISI
$800M
| $836K | 0.01% |
28,684
+8,180
| +40% | +$228K |
|
|
EGOV
672
DELISTED
NIC Inc
EGOV
| $834K | 0.01% |
52,012
-37,075
| -42% | -$613K |
|
673
Seagate
STX
$193B
| $822K | 0.01% |
17,450
+13,160
| +307% | +$612K |
|
674
CytomX Therapeutics
CTMX
$705M
| $821K | 0.01% |
73,151
+2,350
| +3% | +$24.6K |
|
|
CASA
675
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $819K | 0.01% |
+127,383
| New | +$931K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2019 Portfolio in Review
As of Q2 2019, Jacobs Levy Equity Management held 1,100 positions worth $7.23B, up 4.3% from $6.93B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Jacobs Levy Equity Management's Q2 2019 filing shows 151 new, 415 increased, 333 reduced and 164 closed positions. Its largest new stake was Biogen: 175,817 shares worth $41.1M. The largest sale was Allergan plc, an estimated $51.9M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q2 2019 buy was Biogen: 175,817 shares worth $41.1M.
- Jacobs Levy Equity Management added most to Ecolab in Q2 2019, an estimated $35.6M increase.
- Jacobs Levy Equity Management's biggest Q2 2019 reduction was EOG Resources, cutting an estimated $33.8M.
- Jacobs Levy Equity Management fully exited Allergan plc in Q2 2019, selling an estimated $51.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 15% of its $7.23B portfolio in Q2 2019.
- Jacobs Levy Equity Management opened 151 new positions and closed 164 in Q2 2019.
- Jacobs Levy Equity Management's portfolio value rose 4.3% quarter-over-quarter to $7.23B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2019, filed 13 Aug 2019.